Not applicableStudy completedNCT03524924What this trial is testingEdoxaban and Frailty in Senior IndividualsWho this might be right forAtrial Fibrillation University of Padova 180
Not applicableUnknownNCT04315974What this trial is testingItalian Registry In the Setting of AF Ablation With Rivaroxaban (IRIS)Who this might be right forAtrial Fibrillation Dr Carlo Lavalle 250
Not applicableStudy completedNCT04174859What this trial is testingStudy Aims to Collect Information in Routine Clinical Practice in Italy About the Number of Patients Suffering From Irregularly Heart Beats Which Are Not Caused by a Heart Valve Problem (Non-valvular Atrial Fibrillation, NVAF) Who Stopped or Changed Rivaroxaban TreatmentWho this might be right forNon-valvular Atrial Fibrillation Bayer 812
Not applicableLooking for participantsNCT05204212What this trial is testingLeft Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY DiseaseWho this might be right forNon-valvular Atrial Fibrillation (NVAF): Paroxysmal, Persistent, Permanent Prof. Dr. med. Ingo Eitel 430
Not applicableStudy completedNCT01598051What this trial is testingXarelto [SPAF-QOL] Post-marketing Surveillance in JapanWho this might be right forNon-valvular Atrial Fibrillation (NVAF) Bayer 741
Not applicableStudy completedNCT03285373What this trial is testingThis Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in SpainWho this might be right forAtrial Fibrillation Boehringer Ingelheim 1,008
Not applicableStudy completedNCT03446794What this trial is testingLeft Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on HemodialysisWho this might be right forAtrial FibrillationHeart DiseasesRenal Disease+3 more Fundación EPIC 300
Testing effectiveness (Phase 2)Study completedNCT00806624What this trial is testingDU-176b Phase 2 Dose Finding Study in Subjects With Non-valvular Atrial FibrillationWho this might be right forAtrial FibrillationStroke Daiichi Sankyo Co., Ltd. 234
Post-approval studies (Phase 4)UnknownNCT02666157What this trial is testingComparison of Efficacy and Safety Among Dabigatran, Rivaroxaban, and Apixaban in Non-Valvular Atrial FibrillationWho this might be right forAtrial Fibrillation National Cheng-Kung University Hospital 3,672
Not applicableStudy completedNCT02982863What this trial is testingTreatment Pattern of Oral Anticoagulants (OAC) in JapanWho this might be right forAtrial Fibrillation Boehringer Ingelheim 48,696
Large-scale testing (Phase 3)Study completedNCT00403767What this trial is testingAn Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial FibrillationStrokeEmbolism Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 14,269
Not applicableStudy completedNCT03803579What this trial is testingBaseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)Who this might be right forAtrial FibrillationAnticoagulant-induced Bleeding Arianna Anticoagulazione Foundation 2,000
Not applicableStudy completedNCT04356989What this trial is testingStudy to Gain Information on the Drug Xarelto for the Prevention of Brain Attack and Blockage of an Artery in the Non-central Nervous System Due to Irregular Heartbeat in Taiwanese Patients Suffering From Decreased Renal FunctionWho this might be right forNon-valvular Atrial Fibrillation (NVAF) Bayer 493
Post-approval studies (Phase 4)Study completedNCT03061006What this trial is testingImpact of Anticoagulation Therapy on the Cognitive Decline and Dementia in Patients With Non-Valvular Atrial FibrillationWho this might be right forDementiaCognition DisordersCerebral Ischemic Events Intermountain Health Care, Inc. 101
Not applicableStudy completedNCT03526471What this trial is testingOmega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial FibrillationWho this might be right forAtrial Fibrillation Vascular Innovations Co. Ltd. 20
Not applicableStudy completedNCT07152301What this trial is testingInflammation, Epigenetics in CHF Patients With AFWho this might be right forCongestive Heart Failure ChronicAtrial Fibrillation (Permanent) University of Palermo 164
Not applicableLooking for participantsNCT07278869What this trial is testingApplause Study I - Append System Early Feasibility StudyWho this might be right forNon Valvular Atrial Fibrillation Append Medical Ltd. 15
Not applicableStudy completedNCT02654470What this trial is testingWatchman FLX Left Atrial Appendage Closure Device Post Approval Study ( Europe Only)Who this might be right forNon-valvular Atrial Fibrillation Boston Scientific Corporation 300
Not applicableStudy completedNCT03061123What this trial is testingPatient Perceptions and Physician Assessment of Benefits and Risks of Oral Anticoagulation Due to Non-valvular AFWho this might be right forAtrial FibrillationHealth Literacy Medical University of Graz 91
Not applicableStudy completedNCT02461602What this trial is testingEliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation PatientsWho this might be right forAtrial Fibrillation Duke University 251